Did @nytimes just bury the scoop?
"A study by NIH suggests that Moderna’s vaccine works better as a booster than a second shot of J&J."
This appears to be the first mention of results from the NIH J&J+Moderna trial that Fauci said just finished.
nytimes.com/2021/10/04/us/…
"A study by NIH suggests that Moderna’s vaccine works better as a booster than a second shot of J&J."
This appears to be the first mention of results from the NIH J&J+Moderna trial that Fauci said just finished.
nytimes.com/2021/10/04/us/…
Another interesting mention: if boosters for J&J are authorized only after 6mo, J&J can continue to market the vaccine as 1-shot.
Not sure where that policy came from (maybe related to some guidance regarding vaccine durability for EUA application?)
Not sure where that policy came from (maybe related to some guidance regarding vaccine durability for EUA application?)
But I've been wondering what the proper "statute of limitations" is for vaccines. That is, how long until you don't have to consider which other vaccines you are getting for that antigen?
It should be <9mo, as you can take a flu vaccine in January for one manufacturer and October from another.
But if there is a policy that a shot at 6mo is not in the "primary series" but acting more like an annual booster, then maybe the statute of limitations should be 6mo.
But if there is a policy that a shot at 6mo is not in the "primary series" but acting more like an annual booster, then maybe the statute of limitations should be 6mo.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
